Aniara Diagnostica is pleased to announce the availability of
CRP-A Collagen Related Peptide, a strong agonist of Glycoprotein
GPVI receptor platelet activation pathway.
WEST
CHESTER, Ohio, July 11,
2024 /PRNewswire-PRWeb/ -- Aniara Diagnostica, a
multi-national distributor of diagnostic and research agents, as
well as screening tools, has strengthened its commitment to meeting
today's highest standards for product quality and cost-efficient
delivery.
The entire Aniara line is available for
purchase at http://www.aniara.com.
For Research Use Only. Not for Use in Diagnostic Procedures.
CRP-A is the next generation platelet activator offering the
following benefits:
§ Batch to batch consistency on CRP-A response to platelet
activation and aggregation.
§ Minimum dose that causes maximum aggregation is between 0.08
µg/mL and 0.14 µg/mL
§ Minimum dose that causes maximum activation is between 0.22
µg/mL and 0.30 µg/mL
§ CRP-A activity is in the range of concentration from 10 µg/mL
to 0.03 µg/mL
Product Code: ACRP-A click here for more information
The entire Aniara product line is available for purchase at
http://www.aniara.com. The Company distributes products in
North America, Sweden, Norway, Denmark, Finland, Lithuania, Latvia, Estonia and Iceland.
Media Contact
Maria Waldron, Aniara
Diagnostica, 5133423018, mwaldron@aniara.com, www.aniara.com
View original content to download
multimedia:https://www.prweb.com/releases/now-available-from-aniara-diagnostica-crp-a-from-pplus-products-302194479.html
SOURCE Aniara Diagnostica